We are live on ! Find out more
HM

HealthCor Management Portfolio holdings

AUM $109M
1-Year Est. Return 10.64%
This Fund
S&P 500
This Quarter Est. Return
+2.14%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$1.84B
AUM Growth
-$480M
Cap. Flow
-$470M
Cap. Flow %
-25.56%
Top 10 Hldgs %
46.94%
Holding
98
New
25
Increased
8
Reduced
28
Closed
30

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$106M
2
DHR icon
Danaher
DHR
+$46.8M
3
JNJ icon
Johnson & Johnson
JNJ
+$44.6M
4
ELV icon
Elevance Health
ELV
+$42.7M
5
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$33.8M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$104M
2
MCK icon
McKesson
MCK
+$83.1M
3
WELL icon
Welltower
WELL
+$50.9M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$48.6M
5
WOOF icon
Petco
WOOF
+$48.4M

Sector Composition

Rank Sector Weight
1 Healthcare 91.78%
2 Consumer Discretionary 2.94%
3 Financials 1.26%
4 Real Estate 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVS icon
76
CVS Health
CVS
$122B
– –
-173,800
Closed -$14.7M
EHC icon
77
Encompass Health
EHC
$12.4B
– –
-150,337
Closed -$8.97M
FATE icon
78
Fate Therapeutics
FATE
$326M
– –
-128,450
Closed -$7.61M
GHRS icon
79
GH Research
GHRS
$2.08B
– –
-164,912
Closed -$3.64M
IDXX icon
80
Idexx Laboratories
IDXX
$46.2B
– –
-35,800
Closed -$22.3M
INCY icon
81
CALL
Incyte
INCY
$24.4B
– –
-267,000
Closed -$18.4M
MRVI icon
82
Maravai LifeSciences
MRVI
$919M
– –
-250,000
Closed -$12.3M
PRCT icon
83
Procept Biorobotics
PRCT
$1.17B
– –
-37,400
Closed -$1.43M
RCUS icon
84
Arcus Biosciences
RCUS
$3.64B
– –
-70,050
Closed -$2.44M
VRTX icon
85
Vertex Pharmaceuticals
VRTX
$126B
– –
-130,290
Closed -$23.6M
VTR icon
86
Ventas
VTR
$47.9B
– –
-725,010
Closed -$40M
WELL icon
87
Welltower
WELL
$171B
– –
-617,480
Closed -$50.9M
ZBH icon
88
Zimmer Biomet
ZBH
$18.4B
– –
-340,508
Closed -$48.4M
ZTS icon
89
Zoetis
ZTS
$30.5B
– –
-83,060
Closed -$16.1M
DCPH
90
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
– –
-386,190
Closed -$13.1M
MRTX
91
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-9,890
Closed -$1.75M
EUCRU
92
DELISTED
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
– –
-234,180
Closed -$2.32M
ABGI
93
DELISTED
ABG Acquisition Corp. I
ABGI
– –
-329,400
Closed -$3.21M
MSAC
94
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
– –
-744,000
Closed -$7.25M
OMEG
95
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
– –
-271,032
Closed -$2.64M
JYAC
96
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
– –
-140,680
Closed -$1.37M
SRSAU
97
DELISTED
Sarissa Capital Acquisition Corp. Unit
SRSAU
– –
-262,150
Closed -$2.62M
BHVN
98
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-82,183
Closed -$11.4M
1 2 3
4

Similar funds

IA
Integrity Advisory Overland Park, Kansas $109M AUM 15.71% 1-Year Est. Return
EPC
Emerson Point Capital Larchmont, New York $108M AUM 19.03% 1-Year Est. Return
TCMV
Technology Crossover Management VII Menlo Park, California $107M AUM 51.05% 1-Year Est. Return
SI
Salesforce Inc San Francisco, California $114M AUM 53.18% 1-Year Est. Return
HCWM
Harrison & Co Wealth Management Roanoke, Virginia $103M AUM 9.82% 1-Year Est. Return
PC
Phoenician Capital New York $117M AUM 9.46% 1-Year Est. Return
RF
Resolute Financial Newburyport, Massachusetts $118M AUM 11.75% 1-Year Est. Return
AWM
Align Wealth Management Oklahoma City, Oklahoma $118M AUM

HealthCor Management's Q4 2021 Portfolio in Review

As of Q4 2021, HealthCor Management held 98 positions worth $1.84B, down 21% from $2.32B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

HealthCor Management withdrew a net $470M in Q4 2021, closing 30 positions and reducing 28 holdings. Its most notable exit was Welltower, an estimated $50.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, up from 89% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, HealthCor Management opened a new position in Danaher worth $49.5M.

  • HealthCor Management's largest Q4 2021 buy was Danaher: 169,866 shares worth $49.5M.
  • HealthCor Management added most to Medtronic in Q4 2021, an estimated $106M increase.
  • HealthCor Management's biggest Q4 2021 reduction was Bristol-Myers Squibb, cutting an estimated $104M.
  • HealthCor Management fully exited Welltower in Q4 2021, selling an estimated $50.9M.
  • HealthCor Management's ten largest holdings make up 47% of its $1.84B portfolio in Q4 2021.
  • HealthCor Management opened 25 new positions and closed 30 in Q4 2021.
  • HealthCor Management's portfolio value fell 21% quarter-over-quarter to $1.84B.

Based on HealthCor Management's 13F filing for Q4 2021, filed 14 Feb 2022.